Bevacizumab in high-grade gliomas: past, present, and future

Expert Review of Anticancer Therapy
Richard C CurryManmeet S Ahluwalia

Abstract

The survival of patients with high-grade gliomas (anaplastic gliomas and glioblastoma) remains poor despite current treatment modalities. However, an enhanced understanding of gliomagenesis is supporting the development of targeted molecular therapies with the potential for improving clinical outcomes. Glioblastoma (GBM) is characterized by extensive microvascular proliferation and the production of large amounts of VEGF. Bevacizumab is a humanized IgG1 monoclonal antibody that selectively binds with high affinity to human VEGF and neutralizes VEGF's biologic activity. Preclinical data indicate that angiogenesis is essential for the proliferation and survival of GBM cells. A number of studies have evaluated the outcomes of both newly diagnosed and recurrent GBM patients with bevacizumab in a prospective manner. Here, we discuss the role of bevacizumab in the treatment of anaplastic gliomas and GBM in the recurrent and upfront setting.

References

Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Nov 1, 1996·Radiographics : a Review Publication of the Radiological Society of North America, Inc·J H ReesK Wong
Dec 9, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A A BrandesM V Fiorentino
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E T WongW K Yung
Sep 27, 2000·Neoplasia : an International Journal for Oncology Research·J L RubensteinM A Shuman
Mar 16, 2002·Journal of Neuropathology and Experimental Neurology·Paul KleihuesWebster K Cavenee
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerBrian I Rini
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Robert J MotzerM Dror Michaelson
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Nov 28, 2007·Annual Review of Pathology·Janice A NagyHarold F Dvorak
Mar 11, 2008·Cancer·Felix BoksteinDeborah T Blumenthal
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Sep 2, 2008·Neuro-oncology·Andrew D NordenPatrick Y Wen
Sep 17, 2008·International Journal of Radiation Oncology, Biology, Physics·Ashwatha NarayanaMichael L Gruber
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Annick DesjardinsJames J Vredenburgh
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Teri N KreislHoward A Fine
Jan 27, 2009·International Journal of Radiation Oncology, Biology, Physics·Philip H GutinLauren E Abrey
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentSusan M Chang
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickMichael Weller
Nov 17, 2009·Journal of Thrombosis and Haemostasis : JTH·E O JenkinsN S Key
Nov 18, 2009·The British Journal of Surgery·I KumarN J Brown
Feb 20, 2010·European Cytokine Network·Napoleone Ferrara
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Apr 9, 2010·Brain : a Journal of Neurology·Sascha SeidelTill Acker
Apr 10, 2010·Journal of Oncology·Manmeet S Ahluwalia, Candece L Gladson
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy T BatchelorRakesh K Jain
Oct 16, 2010·Cancer Letters·Manmeet S AhluwaliaCandece L Gladson
Dec 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Albert LaiTimothy Cloughesy
Dec 15, 2010·Journal of Neurosurgery·Aaron J ClarkManish K Aghi
Dec 15, 2010·Journal of Neuro-oncology·C Lu-EmersonP Y Wen

❮ Previous
Next ❯

Citations

Nov 7, 2015·Journal of Neuro-oncology·Jeffrey WojtonBalveen Kaur
Jan 21, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Hong DingYuqin Che
Jul 28, 2016·The International Journal of Biochemistry & Cell Biology·Vinay Kumar SharmaSavita Yadav
Mar 28, 2018·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Paulo LinharesRui Manuel Reis
Dec 1, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R F YangZ M Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Expert Review of Anticancer Therapy
Pol Specenier
Expert Opinion on Biological Therapy
Mustafa KhasrawChristian Grommes
© 2021 Meta ULC. All rights reserved